Skip to main content
2026 CRT Conference Main banner

CRT 2026

Beyond the Guidelines

Session:: Beyond the Guidelines | De-Escalation of Antiplatelet Therapy [Non-CME]

Does the Evidence for Ticagrelor Monotherapy Following >1 Month of DAPT Post-PCI for ACS justify Class 1A Guideline Recommendations?

Monday, March 9, 2026
4:08 PM - 4:16 PM EST
Location: Spotlight Theater

    Speaker(s)

  • Sanjay Kaul, MD

    Attending Cardiologist
    Cedars-Sinai Medical Center
    Los Angeles, California, United States

    Disclosure information not submitted.

Disclosure(s):
Davide Capodanno, MD, PhD: Novo Nordisk: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)